Bioactive refinement for endosaccular treatment of intracranial aneurysms

Zoltan Szatmary; Jérémy Mounier; Kevin Janot; Jonathan Cortese; Claude Couquet; Frédéric Chaubet; Ramanathan Kadirvel; Sylvia M. Bardet; Charbel Mounayer; Aymeric Rouchaud

doi:10.1177/19714009211024631

Bioactive refinement for endosaccular treatment of intracranial aneurysms

Zoltan Szatmary, Jérémy Mounier, Kevin Janot, Jonathan Cortese, Claude Couquet, Frédéric Chaubet, Ramanathan Kadirvel, Sylvia M. Bardet, Charbel Mounayer, Aymeric Rouchaud

Radiology

Research output: Contribution to journal › Review article › peer-review

Abstract

Endovascular treatment is the first-line therapy for most intracranial aneurysms; however, recanalisation remains a major limitation. Developments in bioengineering and material science have led to a novel generation of coil technologies for aneurysm embolisation that address clinical challenges of aneurysm recurrence. This review presents an overview of modified surface coil technologies and summarises the state of the art regarding their efficacy and limitations based on experimental and clinical results. We also present potential perspectives to develop biologically optimised devices.

Original language	English (US)
Pages (from-to)	534-541
Number of pages	8
Journal	Neuroradiology Journal
Volume	34
Issue number	6
DOIs	https://doi.org/10.1177/19714009211024631
State	Published - Dec 2021

Keywords

Intracranial aneurysm
bioactive
biological optimisation
coils
endovascular treatment
healing
review

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Clinical Neurology

Access to Document

10.1177/19714009211024631

Cite this

@article{69a1df760853476383308c10ca95d420,

title = "Bioactive refinement for endosaccular treatment of intracranial aneurysms",

abstract = "Endovascular treatment is the first-line therapy for most intracranial aneurysms; however, recanalisation remains a major limitation. Developments in bioengineering and material science have led to a novel generation of coil technologies for aneurysm embolisation that address clinical challenges of aneurysm recurrence. This review presents an overview of modified surface coil technologies and summarises the state of the art regarding their efficacy and limitations based on experimental and clinical results. We also present potential perspectives to develop biologically optimised devices.",

keywords = "Intracranial aneurysm, bioactive, biological optimisation, coils, endovascular treatment, healing, review",

author = "Zoltan Szatmary and J{\'e}r{\'e}my Mounier and Kevin Janot and Jonathan Cortese and Claude Couquet and Fr{\'e}d{\'e}ric Chaubet and Ramanathan Kadirvel and Bardet, {Sylvia M.} and Charbel Mounayer and Aymeric Rouchaud",

note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The study has received support from Project case number: DCM20181039543 financed by Fondation Recherche MĤicale (FRM). Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2021",

month = dec,

doi = "10.1177/19714009211024631",

language = "English (US)",

volume = "34",

pages = "534--541",

journal = "Neuroradiology Journal",

issn = "1971-4009",

publisher = "Centauro srl",

number = "6",

}

TY - JOUR

T1 - Bioactive refinement for endosaccular treatment of intracranial aneurysms

AU - Szatmary, Zoltan

AU - Mounier, Jérémy

AU - Janot, Kevin

AU - Cortese, Jonathan

AU - Couquet, Claude

AU - Chaubet, Frédéric

AU - Kadirvel, Ramanathan

AU - Bardet, Sylvia M.

AU - Mounayer, Charbel

AU - Rouchaud, Aymeric

N1 - Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The study has received support from Project case number: DCM20181039543 financed by Fondation Recherche MĤicale (FRM). Publisher Copyright: © The Author(s) 2021.

PY - 2021/12

Y1 - 2021/12

N2 - Endovascular treatment is the first-line therapy for most intracranial aneurysms; however, recanalisation remains a major limitation. Developments in bioengineering and material science have led to a novel generation of coil technologies for aneurysm embolisation that address clinical challenges of aneurysm recurrence. This review presents an overview of modified surface coil technologies and summarises the state of the art regarding their efficacy and limitations based on experimental and clinical results. We also present potential perspectives to develop biologically optimised devices.

AB - Endovascular treatment is the first-line therapy for most intracranial aneurysms; however, recanalisation remains a major limitation. Developments in bioengineering and material science have led to a novel generation of coil technologies for aneurysm embolisation that address clinical challenges of aneurysm recurrence. This review presents an overview of modified surface coil technologies and summarises the state of the art regarding their efficacy and limitations based on experimental and clinical results. We also present potential perspectives to develop biologically optimised devices.

KW - Intracranial aneurysm

KW - bioactive

KW - biological optimisation

KW - coils

KW - endovascular treatment

KW - healing

KW - review

UR - http://www.scopus.com/inward/record.url?scp=85109190226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109190226&partnerID=8YFLogxK

U2 - 10.1177/19714009211024631

DO - 10.1177/19714009211024631

M3 - Review article

C2 - 34210195

AN - SCOPUS:85109190226

VL - 34

SP - 534

EP - 541

JO - Neuroradiology Journal

JF - Neuroradiology Journal

SN - 1971-4009

IS - 6

ER -

Bioactive refinement for endosaccular treatment of intracranial aneurysms

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this